You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

etoposide

Showing 26 - 50 of 1,852
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Tumor Recurrent Trial in Houston (Methotrexate, Etoposide, Ommaya Reservoir)

Recruiting
  • Brain Tumor Recurrent
  • Houston, Texas
    UTHealth & Children's Memorial Hermann Hospital
Aug 17, 2022

Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Gainesville (Ciprofloxacin 750 MG, Etoposide,

Terminated
Has Results
  • Leukemia
  • +2 more
  • Ciprofloxacin 750 MG
  • +3 more
  • Gainesville, Florida
    UF Health Shands Cancer Hospital
Jul 5, 2022

Extensive-stage Small-cell Lung Cancer Trial in China (serplulimab, Cisplatin, Carboplatin)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Shantou, Guangdong, China
  • +6 more
Mar 1, 2023

Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Hematological Malignancy
  • Etoposide
  • +2 more
  • Ningbo, Zhejiang, China
    The Affiliated People's Hospital of Ningbo University.
Aug 18, 2022

Glioblastoma Multiforme Trial in Edmonton (Tamoxifen, Etoposide)

Recruiting
  • Glioblastoma Multiforme
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Mar 28, 2022

Outcomes ofBrazilian Cohort of Previously Untreated Extensive

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Observational study
  • (no location specified)
Aug 24, 2023

Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Durvalumab 50 MG/1 ML Intravenous Solution
  • +4 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 31, 2022

Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Neuroendocrine Neoplasms
  • BI 764532
  • +3 more
  • (no location specified)
Nov 10, 2023

Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in United States (Everolimus, Nelarabine, Cyclophosphamide)

Recruiting
  • Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Atlanta, Georgia
  • +3 more
Aug 18, 2022

Extensive Stage Small Cell Lung Cancer Trial in France ([177Lu]Lu-DOTA-TATE, Tislelizumab, [68Ga]Ga-DOTA-TATE)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Lille, France
  • +6 more
Jan 23, 2023

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Cisplatin, Carboplatin)

Active, not recruiting
  • Carcinoma, Small Cell Lung
  • Beijing City, China
  • +7 more
Nov 24, 2022

Diffuse Large B Cell Lymphoma Trial (Venetoclax, Carmustine, Cytarabine)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
May 9, 2023

SCLC,Extensive Stage Trial in Omaha (RYZ101 Dose Level 1, RYZ101 Dose Level 2, RYZ101 Dose Level 3)

Recruiting
  • SCLC,Extensive Stage
  • RYZ101 Dose Level 1
  • +6 more
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Nov 18, 2022

DLBCL (DLBCL) Trial (Glofitamab, Obinutuzumab, Tocilizumab)

Recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Pembroke Pines, Florida
  • +3 more
Jan 23, 2023

Small Cell Lung Cancer Trial in Fuzhou (Surufatinib,Serplulimab,Etoposide,Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
May 20, 2023

Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

Recruiting
  • Ependymoma
  • +3 more
  • Augusta, Georgia
    Augusta University, Georgia Cancer Center
Dec 16, 2022

Extensive Stage Small Cell Lung Cancer Trial in Shanghai (HLX10, carboplatin and etoposide, )

Active, not recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Shanghai, China
  • +5 more
Sep 28, 2022

Effect of Drug, Toxicity, Drug, Secondary Resistance Trial in Beijing (Apatinib Mesylate, ifosfamide and etoposide)

Completed
  • Effect of Drug
  • +2 more
  • Apatinib Mesylate
  • ifosfamide and etoposide
  • Beijing, Beijing, China
    Peking University People's Hospital
Mar 12, 2022

Extensive Stage Small Cell Lung Cancer Trial in Shanghai (recombinant anti-PD-L1 mAb injection combined with carboplatin and

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • recombinant anti-PD-L1 monoclonal antibody injection combined with carboplatin and etoposide
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
May 9, 2022

Small Cell Lung Cancer Trial in Spain (BMS-986012, Cisplatin, Etoposide)

Active, not recruiting
  • Small Cell Lung Cancer
  • Barcelona, Spain
  • +3 more
Apr 25, 2022

B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • (no location specified)
Aug 7, 2023

CNS Lymphoma, Secondary CNS Lymphoma Trial run by the National Cancer Institute (NCI) (TEDD-R, TEDDI-R, Ibrutinib)

Recruiting
  • Central Nervous System Lymphoma
  • Secondary Central Nervous System Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • BI 764532
  • +5 more
  • (no location specified)
Oct 17, 2023

DLBCL Trial in Qingdao (Selinexor combined with Prednisone, Etoposide, and Lenalidomide)

Not yet recruiting
  • DLBCL
  • Selinexor combined with Prednisone, Etoposide, and Lenalidomide
  • Qingdao, Shandong, China
    the affiliated hospital of Qingdao University
Aug 18, 2022